SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-068301
Filing Date
2021-05-17
Accepted
2021-05-17 17:16:01
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2112994d1_10q.htm 10-Q 489250
2 EXHIBIT 31.1 tm2112994d1_ex31-1.htm EX-31.1 7720
3 EXHIBIT 31.2 tm2112994d1_ex31-2.htm EX-31.2 7730
4 EXHIBIT 32.1 tm2112994d1_ex32-1.htm EX-32.1 4325
5 EXHIBIT 32.2 tm2112994d1_ex32-2.htm EX-32.2 4225
  Complete submission text file 0001104659-21-068301.txt   5198284

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ontx-20210331.xml EX-101.INS 1364152
7 XBRL TAXONOMY EXTENSION SCHEMA ontx-20210331.xsd EX-101.SCH 50224
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ontx-20210331_cal.xml EX-101.CAL 35018
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ontx-20210331_def.xml EX-101.DEF 186259
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ontx-20210331_lab.xml EX-101.LAB 433348
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ontx-20210331_pre.xml EX-101.PRE 326101
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 21932347
SIC: 2834 Pharmaceutical Preparations